Ellence Related Clinical Trials
Adjuvant Epirubicin/Cytoxan Followed By A Taxane VS. Epirubicin/Taxane As Treatment For Node-Positive Breast Cancer [Terminated]
Study of Docetaxel in Breast Cancer Patients [Completed]
A Phase I, Open-label, Study of Pazopanib in Combination With Epirubicin or Doxorubicin for Advanced Solid Tumors [Recruiting]
Epirubicin and Docetaxel Combination (ET) or Epirubicin Followed by Docetaxel (E/T) for Node Negative (N0) High Risk Breast Cancer Patients [Recruiting]
Dinaciclib and Epirubicin Hydrochloride in Treating Patients With Metastatic Triple-Negative Breast Cancer [Recruiting]
Panther: A Study Comparing Biweekly and Tailored EC-T Versus Three Weekly FEC-T in Breast Cancer Patients [Recruiting]
Epirubicin or Not in Patients With TOP2A (Topoisomerase (DNA) II Alpha (170kD)) Normal Early Breast Cancer [Recruiting]
Predictors for Response to Dose-dense Docetaxel and Epirubicin Breast Cancer [Recruiting]
A Study of Epirubicin With Estramustine Phosphate and Celecoxib for the Treatment of Prostate Cancer [Recruiting]
A Study of Genetic Based Chemotherapy Dosing for Breast Cancer Patients [Recruiting]
Randomized Neoadjuvant Study of Epirubicin and Docetaxel With/Without Capecitabine in Early Breast Cancer [Recruiting]
Neoadjuvant Chemotherapy for Operable Premenopausal Breast Cancer Patients [Recruiting]
Epirubicin and Cyclophosphamide Compared With Epirubicin and Paclitaxel in Treating Women With Metastatic Breast Cancer [Active, not recruiting]
REAL 3 Version 2.0: Trial of the Efficacy of Epirubicin, Oxaliplatin and Capecitabine (EOX) With or Without Panitumumab in Previously Untreated Advanced Oesophago-Gastric Cancer [Recruiting]
Preoperative Epirubicin Paclitaxel Aranesp Study (PREPARE) [Active, not recruiting]
Epirubicin and Docetaxel in the Treatment of Patients With Metastatic Breast Cancer [Terminated]
Comparison Study of Neoadjuvant Paclitaxel Plus Carboplatin/Epirubicin Treatment in Triple-negative Breast Cancer [Recruiting]
Gemcitabine, Cisplatin, Epirubicin, and Capecitabine in Treating Patients With Stage I-II Resectable Pancreatic Cancer [Recruiting]
Panobinostat and Epirubicin in Treating Patients With Metastatic Malignant Solid Tumors [Recruiting]
Adjuvant Chemotherapy for Elderly Non Frail Patients With an Increased Risk for Relapse of a Primary Carcinoma of the Breast [Recruiting]
Early Cardiac Toxicity of Adjuvant CT in Elderly BC. [Not yet recruiting]
A Translational Trial on Molecular Markers and Functional Imaging to Predict Response of Preoperative Treatment of Breast Cancer Early [Recruiting]
Cytoxan, Epirubicin and Capecitabine in Women With Breast Cancer [Active, not recruiting]
Panitumumab, Nab-paclitaxel and Carboplatin for HER2 Negative Inflammatory Breast Cancer [Recruiting]
Cisplatin, Capecitabine, Gemcitabine Hydrochloride and Epirubicin Hydrochloride or Docetaxel in Treating Patients With Stage III or Stage IV Pancreatic Cancer [Recruiting]
Phase II Study of Cisplatin Plus Epirubicin Salvage Chemo in Refractory Germ Cell Tumors [Terminated]
Neoadjuvant Study of Sequential Eribulin Followed by FAC Compared to Sequential Paclitaxel Followed by FEC in Early Stage Breast Cancer Not Overexpressing HER-2 [Recruiting]
Dose-Dense Epirubicin and Cyclophosphamide (EC) Followed by Paclitaxel in Breast Cancer: Feasibility [Active, not recruiting]
Study of Epirubicin (PharmorubicinŽ), Carboplatin (ParaplatinŽ) and Capecitabine (XelodaŽ) (ECC) in the Treatment of Unresectable Locally Advanced or Metastatic Gastric/Gastroesophageal Junction Cancer With Pharmacogenetic Correlates [Recruiting]
Randomized Phase III Trial With Docetaxel Plus Epirubicine Versus Docetaxel Plus Capecitabine for Metastatic Breast Cancer [Completed]
Randomized Phase II Study of Epirubicin vs Caelyx in Pretreated Metastatic Breast Cancer [Recruiting]
Weekly Gemcitabine, Epirubicin, and Docetaxel in Locally Advanced or Inflammatory Breast Cancer [Active, not recruiting]
Phase I Trial of Valproic Acid and Epirubicin in Solid Tumor Malignancies [Recruiting]
Phase I Combination w/ Epirubicin [Recruiting]
Epirubicin, Oxaliplatin, and Capecitabine or Docetaxel and Oxaliplatin in Treating Patients With Advanced Esophageal Cancer, Gastroesophageal Junction Cancer, or Stomach Cancer [Recruiting]
Efficacy and Safety Study of Trastuzumab and Paclitaxel Based Regimens to Treat HER2-positive Breast Cancer [Recruiting]
Sorafenib, Epirubicin, Ifosfamide, and Radiation Therapy Followed By Surgery in Treating Patients With High-Risk Stage II or Stage III Soft Tissue Sarcoma [Recruiting]
A Comparative Study of Salvage Treatment With Combination of Docetaxel and Epirubicin [Not yet recruiting]
Epirubicin and Celecoxib in Treating Patients With Hepatocellular Carcinoma [Active, not recruiting]
Sulindac and Epirubicin in Treating Patients With Metastatic Malignant Melanoma [Recruiting]
Docetaxel Followed by CEF (Cyclophosphamide, Epirubicin and 5-Fluorouracil) Compared to Docetaxel and Capecitabine Followed by CEX (Cyclophosphamide, Epirubicin and Capecitabine) as Adjuvant Treatment for Breast Cancer [Completed]
EC (Epirubicin, Cyclophosphamide) Followed by T (Docetaxel) Versus ET (Epirubicin, Docetaxel) Followed by X (Capecitabine) as Adjuvant Chemotherapy for Node Positive Operable Breast Cancer Patients [Completed]
Adjuvant Treatment of Breast Cancer With 1-3 Aflicted Lymph Nodes [Active, not recruiting]
Epirubicin and Tamoxifen With or Without Docetaxel in Treating Postmenopausal Women With Breast Cancer [Active, not recruiting]
Therapy With Bevacizumab (BEV), Epirubicin, and Cyclophosphamide Followed by Docetaxel Plus Trastuzumab and BEV Given as Neoadjuvant or Adjuvant Therapy for Women With Locally Advanced HER2 Positive Invasive Breast Cancer [Recruiting]
Epirubicin and Thalidomide in Treating Patients With Liver Cancer [Completed]
5-FU, Leucovorin, Oxaliplatin and Docetaxel (FLOT) Versus Epirubicin, Cisplatin and 5-FU (ECF) in Patients With Locally Advanced, Resectable Gastric Cancer [Recruiting]
Melanoma Epirubicin Sulindac Trial: Sulindac in Combination With Epirubicin in Patients With Advanced Melanoma [Recruiting]
Epirubicin in Treating Women Who Are Undergoing Surgery for Stage I, Stage II, or Stage III Breast Cancer [Suspended]
Study of Alimta and Epirubicin Administered in Patients With Locally Advanced or Metastatic Breast Cancer [Completed]
Epirubicin and Rituximab in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia [Active, not recruiting]
Comparative Study on Two Post-operative Adjuvant Chemotherapy Regimens for Treating Triple-negative Breast Cancer [Recruiting]
A Study of Gemcitabine, Epirubicin, and Paclitaxel Combination Chemotherapy Given Before Surgery to Patients With Locally Advanced Breast Cancer [Completed]
Capecitabine, Epirubicin, and Carboplatin in Treating Patients With Progressive, Unresectable, or Metastatic Cancer [Recruiting]
Neoadjuvant Chemotherapy of Primary Breast Cancer With Epirubicin/Docetaxel and Carboplatin/Docetaxel [Active, not recruiting]
ECX + Panitumumab vs. ECX Alone in Locally Advanced Gastric Cancer or Cancer of the Gastroesophageal Junction [Recruiting]
Docetaxel/Epirubicin/Bevacizumab as First Line Therapy for Metastatic HER2 Negative Breast Cancer [Recruiting]
Lapatinib and Epirubicin in Treating Patients With Metastatic Breast Cancer [Recruiting]
Gemcitabine/Cisplatin Vs Gemcitabine/Epirubicin for NSCLC [Recruiting]
Epirubicin and Docetaxel in Treating Patients With Metastatic Prostate Cancer [Suspended]
Neoadjuvant Endostatin and Chemotherapy for Breast Cancer [Recruiting]
Epirubicin, Docetaxel, and Capecitabine in Treating Women With Stage IIIA or Stage IIIB Breast Cancer [Active, not recruiting]
Dose Density FU 75 and FU 90 as Adjuvant Therapy for Early Breast Cancer [Completed]
Combination Chemotherapy With or Without Epirubicin in Treating Women With Stage I or Stage II Breast Cancer [Active, not recruiting]
Docetaxel and Epirubicin in Advanced Gastric Cancer [Recruiting]
Neoadjuvant or Adjuvant Epirubicin, Cyclophosphamide, and Paclitaxel in Treating Women With Stage I, Stage II, or Stage III Breast Cancer [Active, not recruiting]
Molecular Triaging of Newly Diagnosed Breast Cancer [Not yet recruiting]
Paclitaxel and Carboplatin With or Without Epirubicin in Treating Patients With Stage IIB, Stage III, or Stage IV Invasive Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer [Completed]
An Investigation of the Effect of the Promoter Polymorphism in the Glucuronosyltransferase 2B7 in Patients on Breast Cancer Treatment [No longer recruiting]
Combination Chemotherapy With or Without Metformin Hydrochloride in Treating Patients With Metastatic Pancreatic Cancer [Recruiting]
Continuous Infusion of FU Combined With Epirubicin and Oxaliplatin in Patients With A/MGC [Recruiting]
Gemcitabine and Epirubicin in Treating Patients With Malignant Mesothelioma [Completed]
Epirubicin, Carboplatin, and Capecitabine in Treating Patients With Unresectable Locally Advanced, Metastatic, or Recurrent Solid Tumor
Epirubicin and Vinorelbine in Treating Patients With Stage II, Stage III, or Stage IV Breast Cancer [Recruiting]
Phase I- Lapatinib and Epirubicin Study [Recruiting]
Docetaxel and Epirubicin With and Without G-CSF in Treating Women With Metastatic Breast Cancer
Neoadjuvant Epirubicin, Cyclophosphamide, and Paclitaxel With or Without Gemcitabine in Treating Women Who Are Undergoing Surgery for Early Breast Cancer
Neoadjuvant Chemotherapy + Herceptin in HER2 Positive Stage II-III Breast Cancer Patients [Recruiting]
Epirubicin Plus Irinotecan in Treating Patients With Advanced Cancer [Active, not recruiting]
Neo-Adjuvant Gemcitabine, Epirubicin, ABI-007 (GEA) in Locally Advanced or Inflammatory Breast Cancer [Active, not recruiting]
Doxorubicin or Epirubicin and Cyclophosphamide in Treating Older Women With Invasive Breast Cancer [Recruiting]
DPPE in Combination With Epirubicin and Cyclophosphamide in the Treatment of Breast Cancer
Epirubicin, Docetaxel, and Pegfilgrastim in Treating Women With Locally Advanced or Inflammatory Breast Cancer [Recruiting]
Epirubicin and Cyclophosphamide Followed By Docetaxel and Trastuzumab in Treating Women With HER2-Positive Stage III or Stage IV Breast Cancer [Recruiting]
Pharmacokinetic Study of Tesmilifene (YMB1002) Plus Epirubicin and Cyclophosphamide in Metastatic Breast Cancer [Active, not recruiting]
Topoisomerase II Alpha Gene Amplification and Protein Overexpression Predicting Efficacy of Epirubicin [Recruiting]
Pre-Operative Epirubicin, Cisplatin, and Capecitabine in Patients With Newly Diagnosed Localised Oesophageal Adenocarcinoma [Recruiting]
Docetaxel and Epirubicin as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Adenocarcinoma of the Stomach [No longer recruiting]
Combination Chemotherapy in Treating Patients With Extensive Stage Small Cell Lung Cancer [No longer recruiting]
Adjuvant Chemoradiation Therapy for Gastric or Gastroesophageal Junction Adenocarcinoma [No longer recruiting]
Phase II Study of Epirubicin, Cisplatin and Capecitabine (ECX) Versus Cisplatin and Capecitabine (CX) for Advanced Gastric Cancer (AGC) [Recruiting]
Combination Chemotherapy in Treating Women With Stage II or Stage III Breast Cancer [Active, not recruiting]
Combination Chemotherapy in Treating Women With Resected Breast Cancer [No longer recruiting]
Intravesical Epirubicin Plus BCG to Prevent the Recurrence of Transitional Cell Carcinoma of Bladder [Completed]
Epirubicin Cisplatin and Fluorouracil (FU) Combined With Endostar in Patients With Advanced or Metastatic Gastric Cancer [Recruiting]
Docetaxel, Epirubicin, and Cyclophosphamide With or Without Trastuzumab in Treating Women With Locally Advanced Breast Cancer That Can Be Removed By Surgery [Recruiting]
Combination Chemotherapy Following Surgery in Treating Women With Early Stage Breast Cancer [No longer recruiting]
Neoadjuvant ECX Followed by Definitive Chemoradiation With/Without Surgery for Squamous Cell Carcinoma of the Oesophagus [Recruiting]
Combination Chemotherapy in Treating Women With Breast Cancer Who Have Undergone Surgery [No longer recruiting]
Perioperative Panitumumab and Epirubicin, Oxaliplatin and Xeloda (EOX) in Patients With Gastroesophageal Adenocarcinoma [Recruiting]
A Phase III Trials Program Exploring the Integration of Bevacizumab, Everolimus (RAD001), and Lapatinib Into Current Neoadjuvant Chemotherapy Regimes for Primary Breast Cancer [Recruiting]
|
